08.23.2012

Regulatory Arbitrage Fears Over OTC Derivative Regulations

08.23.2012
Terry Flanagan

As regulators around the world busily try to meet their G20 commitments to reforming the $700 trillion over-the-counter derivatives markets, there are real worries that the application of the new rules will lead to either regulatory arbitrage or increased costs for many international firms.

Regulators across different jurisdictions are currently in the process of implementing new regulations that aim to standardize many OTC derivatives contracts and push them on to exchange-like venues where they will be cleared centrally and reported to trade repositories in a bid to improve transparency and mitigate systemic risk. The G20 demanded that this process be complete by the end of this year, although it appears that this deadline may not now be met.

In Europe, the European Market Infrastructure Regulation (Emir), which is the European Union’s attempt at better regulating the region’s OTC derivatives markets, is not now likely to be in place before July 2013 at the earliest, while the Dodd-Frank Act, the U.S. version, is further advanced following the publication of swap definitions earlier this month, which initiated a 60-day countdown for compliance to key parts of the Act. Asia, meanwhile, is more up in the air as there is no single regulator overseeing the region.

“Dodd-Frank is a little bit ahead of Emir in terms of the G20 commitments,” Dr Christian Voigt, business solutions architect at Fidessa, a trading technology company, told Markets Media.

Dr Christian Voigt, business solutions architect, Fidessa

Dr Christian Voigt, business solutions architect, Fidessa

“Asia is more complicated. In the U.S. at least you’re dealing with just one jurisdiction while with Asia, you are talking about so many different countries. You’ve got Singapore, Hong Kong, Tokyo and Sydney all operating under different regulatory regimes which makes it even more difficult. The risk of regulatory arbitrage is very high and we have seen this through history a number of times.”

There are fears that many firms may set up in parts of Asia where the regulations are more lax in a bid to capitalize on potential regulatory loopholes.

“Regulatory arbitrage is a somewhat inevitable part of any global business in so far as managers will seek the simplest way to operate under existing rules,” said Voigt. “So it is definitely a huge risk, especially for Europe which is facing considerable economic challenges and could potentially lose out to the global markets. Europe needs to be very careful on how it goes forward on this.”

On the subject of extraterritoriality, calls are growing for individual jurisdictions to get their house in order first, before solving the thorny issue of applying the OTC derivatives rules across borders.

In a joint letter last week to U.S. regulator the Commodity Futures Trading Commission (CFTC), Japan’s Financial Services Agency (FSA), its financial regulator, and the Bank of Japan, its central bank, urged the CFTC to ease back on its application of extraterritorial OTC derivatives rules.

“We urge the CFTC to consider deferring the application of its regulations on cross-border transactions until an internationally consistent approach on how to address cross-border regulation of OTC derivatives would be developed,” said Masamichi Kono, vice-commissioner for international affairs at the FSA, and Hideo Hayakawa, executive director of the Bank of Japan.
Market participants are also worried that extraterritoriality will bring with it unnecessary costs.

“There are a number of different approaches between regulators,” said Voigt at Fidessa. “Third country discussions have not been resolved yet. What do the U.S. regulators [CFTC and Securities and Exchange Commission] require from European businesses in order for them to operate in their jurisdiction and vice versa? There is the real risk that a number of large international players will face massive overheads because they have to adhere to multiple regulations.

“This topic will definitely come under discussion [in Europe] between now and mid-2013 as Europe has to implement Emir and people will start to ask questions [such as] how do I do business in the U.S. or how does a U.S. company do business with me in Europe?”

It's been a month since we had our Women In Finance Awards in New York City at the Plaza! Take a look back tab some moments, and nominate for our upcoming awards in Mexico City and Singapore here: https://www.marketsmedia.com/category/events/

4

Citadel Securities told the SEC that trading tokenized equities should remain under existing market rules, a position that drew responses from various crypto industry groups. @ShannyBasar for @MarketsMedia:

SEC Commissioner Mark Uyeda argued that private assets belong in retirement plans, saying diversified alts can improve risk-adjusted returns and that the answer to optimal exposure “is not zero.” @ShannyBasar reporting for @MarketsMedia:

COO of the Year Award winner! 🏆
Discover how Jennifer Kaiser of Marex earned the 2025 Women in Finance COO of the Year recognition.

Load More

Related articles

  1. MiFID II Prompts Banks to Keep Time

    Due to late trading, retail investors can now react better to changes on US stock exchanges.

  2. Daily Email Feature

    Euronext Transforms Over a Decade

    Stéphane Boujnah talks about his 10 years in charge.

  3. The collaboration will allow EuroCTP to validate its data quality control designs.

  4. Buy Side Responds to Esma on Clearing Swaps

    ESMA will consider new topics in 2026 that may need intensified supervisory work in the following years.

  5. Policymakers have the opportunity to address these areas in the upcoming legislative package.

We're Enhancing Your Experience with Smart Technology

We've updated our Terms & Conditions and Privacy Policy to introduce AI tools that will personalize your content, improve our market analysis, and deliver more relevant insights.These changes take effect on Aug 25, 2025.
Your data remains protected—we're simply using smart technology to serve you better. [Review Full Terms] | [Review Privacy Policy] Please review our updated Terms & Conditions and Privacy Policy carefully. By continuing to use our services after Aug 25, 2025, you agree to these

Close the CTA